ESPR icon

Esperion Therapeutics

148 hedge funds and large institutions have $426M invested in Esperion Therapeutics in 2022 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 59 increasing their positions, 41 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
148
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$22.5M
Puts
$4.14M
Net Calls
Net Calls Change

Top Buyers

1 +$11.6M
2 +$7.18M
3 +$5.25M
4
SSA
Schonfeld Strategic Advisors
New York
+$4.98M
5
Two Sigma Investments
Two Sigma Investments
New York
+$4.6M

Top Sellers

1 -$6.59M
2 -$3.37M
3 -$3.21M
4
DTC
Deep Track Capital
Connecticut
-$2.43M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$2.36M
Name Holding Trade Value Shares
Change
Change in
Stake
76
$227K
77
$214K
78
$212K
79
$201K
80
$200K
81
$197K
82
$193K
83
$185K
84
$183K
85
$178K
86
$176K
87
$176K
88
$174K
89
$168K
90
$167K
91
$155K
92
$136K
93
$125K
94
$122K
95
$113K
96
$108K
97
$105K
98
$105K
99
$98K
100
$95K